| The role of genetic polymorphism and other factors on clopidogrel resistance (CR) in an Asian population with coronary heart disease (CHD) MA Akkaif, NAA Daud, A Sha’aban, ML Ng, MAS Abdul Kader, DAM Noor, ... Molecules 26 (7), 1987, 2021 | 73 | 2021 |
| A review of the effects of ticagrelor on adenosine concentration and its clinical significance MA Akkaif, ML Ng, MA SK Abdul Kader, NAA Daud, A Sha’aban, ... Pharmacological Reports 73 (6), 1551-1564, 2021 | 49 | 2021 |
| Antihypertensive medications for severe hypertension in pregnancy: A systematic review and meta-analysis A Awaludin, C Rahayu, NAA Daud, N Zakiyah Healthcare 10 (2), 325, 2022 | 19 | 2022 |
| Investigate the strategy of using pharmacogenetics and pharmacometabonomics to the personalization of ticagrelor antiplatelet therapy MA Akkaif, A Sha’aban, NAA Daud, ML Ng, B Ibrahim Syst. Rev. Pharm 11 (9), 1100-1107, 2020 | 17 | 2020 |
| Coronary Heart Disease (CHD) in elderly patients: which drug to choose, ticagrelor and clopidogrel? A systematic review and meta-analysis of randomized controlled trials MA Akkaif, A Sha’aban, NAA Daud, I Yunusa, ML Ng, MA Sk Abdul Kader, ... Journal of cardiovascular development and disease 8 (10), 123, 2021 | 16 | 2021 |
| Physicians’ perceived barriers and enablers for deprescribing among older patients at public primary care clinics: a qualitative study B Tangiisuran, V Rajendran, A Sha’aban, NAA Daud, SNM Nawi International Journal of Clinical Pharmacy 44 (1), 201-213, 2022 | 14 | 2022 |
| The management of myocardial injury related to SARS-CoV-2 pneumonia MA Akkaif, AN Bitar, LAIK Al-Kaif, NAA Daud, A Sha’aban, DAM Noor, ... Journal of Cardiovascular Development and Disease 9 (9), 307, 2022 | 10 | 2022 |
| Genetic Determinants in HLA and Cytochrome P450 Genes in the Risk of Aromatic Antiepileptic-Induced Severe Cutaneous Adverse Reactions AF Ahmed, C Sukasem, MA Sabbah, NF Musa, DA Mohamed Noor, ... Journal of Personalized Medicine 11 (5), 383, 2021 | 8 | 2021 |
| Knowledge, attitude and perception of community pharmacists towards pharmacogenomics services in northern Nigeria: a cross-sectional study U Abubakar, L Subramaniam, A Ayinla, MN Ambali, DA Mohamed Noor, ... Journal of Pharmaceutical Policy and Practice 15 (1), 39, 2022 | 6 | 2022 |
| M., & Ibrahim, B.(2021). The Role of Genetic Polymorphism and Other Factors on Clopidogrel Resistance (CR) in an Asian Population with Coronary Heart Disease (CHD) MA Akkaif, NAA Daud, A Sha’aban, ML Ng, MAS Abdul Kader, DA Noor Molecules 26 (7), 1987 | 5 | 1987 |
| Factors associated with intimate partner violence and barriers to reporting it, among female who use drugs in Malaysia D Singh, A Anandan, S Narayanan, NA Athirah Daud, A Azman, ... Drugs: Education, Prevention and Policy 29 (5), 614-624, 2022 | 4 | 2022 |
| Reliability and Validity of the Malay Version of the Return and Disposal of Unused Medications (Redium) Questionnaire in Malaysia and the General Public’s Knowledge, Attitude … SC Ong, IK Chhabra, GS Ooi, NA Athirah Daud, AA Shafie, A Hassali, ... Malaysian Journal of Medicine & Health Sciences, 2021 | 4 | 2021 |
| Awareness, Attitude and Behaviour Related to the Intake of Dietary Supplements among Malaysian Pregnant Women. NAA Daud, SA Mukhlef, FA Aziz Malaysian Journal of Medicine & Health Sciences 16 (4), 2020 | 4 | 2020 |
| Platelet reactivity index after treatment of clopidogrel versus ticagrelor based on CYP2C19 genotypes among patients undergoing percutaneous coronary intervention: results of a … MA Akkaif, NAA Daud, DAM Noor, A Sha'aban, MJA Wahab, ... European Heart Journal 44 (Supplement_1), ehac779. 120, 2023 | 3 | 2023 |
| Fast and more affordable CYP2C19 LOF testing to personalized of clopidogrel therapy MA Akkaif, A Sha'aban, NAA Daud, DAM Noor, NF Musa, ... European heart journal 43 (Supplement_2), ehac544. 3025, 2022 | 3 | 2022 |
| The use of ticagrelor versus clopidogrel in Malaysian patients with coronary artery disease undergoing percutaneous coronary intervention (PCI): Does the age tertile affect the … MA Akkaif, NAA Daud, DAM Noor, A Sha'aban, MA Sk Abdul Kader, ... European Heart Journal 44 (Supplement_1), ehac779. 122, 2023 | 2 | 2023 |
| Ethical considerations of the genetic testing for patients with cardiovascular disease MA Akkaif, NAA Daud Malaysian Journal of Human Genetics 3 (1), 13-17, 2022 | 2 | 2022 |
| Association between CYP3A4/CYP3A5 genetic polymorphisms and treatment outcomes of atorvastatin worldwide: is there enough research on the Egyptian population? MG Maslub, MA Radwan, NAA Daud, A Sha’aban European Journal of Medical Research 28 (1), 381, 2023 | 1 | 2023 |
| SLEEP QUALITY AND QUALITY OF LIFE AMONG MALAYSIAN PHARMACY UNDERGRADUATE STUDENTS NNM Hanapi, SC Ong, GS Ooi, NAA Daud Malaysian Journal of Pharmaceutical Sciences 19 (1), 65-75, 2021 | 1 | 2021 |
| MA; Abdul Wahab, MJ; et al. The Management of Myocardial Injury Related to SARS-CoV-2 Pneumonia MA Akkaif, AN Bitar, L Al-Kaif, NAA Daud, A Sha’aban, DAM Noor, ... J. Cardiovasc. Dev. Dis, 0 | 1 | |
